Select for export Psilocybin for depression: Considerations for clinical trial design Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2019.026 Copy citation Copy BibTeX Journal of Psychedelic Studies 2019-08-31 Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export The Potential of Psilocybin Administration in Terminal Cancer Patients Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/01.cot.0000574916.46844.cf Copy citation Copy BibTeX Oncology Times 2019-06-27 Richard Simoneaux OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/adt.0000000000000178 Copy citation Copy BibTeX Addictive Disorders & Their Treatment 2019-06-09 Doreen M. Lewis OpenAlex Published psilocybin AnxietyReceptor PharmacologyEmotional Processing Observational Study More
Select for export A Study of Psilocybin for Major Depressive Disorder (MDD) No abstract availability was recorded for this entry. Details DOI 10.31525/ct1-nct03866174 Copy citation Copy BibTeX Case Medical Research 2019-03-06 Kernel Networks Inc. OpenAlex Published psilocybin Depression Other More
Select for export Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2019.01.002 PubMed 30611836 Copy citation Copy BibTeX Unknown journal 2019-01-02 Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z Europe PMC Published psilocybin DepressionSystematic ReviewReview Article Systematic Review More
Select for export DARK Classics in Chemical Neuroscience: Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.8b00186 PubMed 29956917 Copy citation Copy BibTeX Unknown journal 2018-07-15 Geiger HA, Wurst MG, Daniels RN. Europe PMC Published psilocybinpsilocin DepressionAddictionEnd-of-Life Distress Review Article More
Select for export Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2018.01.006 PubMed 29407543 Copy citation Copy BibTeX Journal of Affective Disorders 2018-03-31 Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J Europe PMC Published psilocybin DepressionTreatment-Resistant Depression Other More
Select for export Rapid-Acting Antidepressants. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1381612824666180730104707 PubMed 30058481 Copy citation Copy BibTeX Unknown journal 2017-12-31 Witkin JM, Knutson DE, Rodriguez GJ, Shi S. Europe PMC Published psilocybin DepressionReceptor PharmacologyReview Article Review Article More
Select for export Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-017-4771-x PubMed 29119217 Copy citation Copy BibTeX Psychopharmacology 2017-11-07 Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE Europe PMC Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export The fibrinolytic system: A new target for treatment of depression with psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.mehy.2017.01.013 PubMed 28236848 Copy citation Copy BibTeX Unknown journal 2017-01-22 Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S. Europe PMC Published psilocybin DepressionNeuroplasticityNeurogenesis Other More
Select for export Psychedelics in the treatment of unipolar mood disorders: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116679368 PubMed 27856684 Copy citation Copy BibTeX Unknown journal 2016-11-16 Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH. Europe PMC Published psilocybin DepressionClinical TrialSystematic Review Systematic Review More
Select for export Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(16)30065-7 PubMed 27210031 Copy citation Copy BibTeX The Lancet Psychiatry 2016-05-16 Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(15)30017-1 Copy citation Copy BibTeX European Psychiatry 2015-02-28 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Psychedelics and mental health: a population study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0063972 PubMed 23976938 Copy citation Copy BibTeX PLoS ONE 2013-08-18 Krebs TS, Johansen PØ. Europe PMC Published psilocybin DepressionAnxietyPTSD Observational Study More